New Bispecific Antibody Demonstrates Clinical Activity in Patients With Multiple Myeloma
REGN5459 had decreased binding affinity to T cells, resulting in an encouraging side effect profile and efficacy ORLANDO, Fla....
Search/Filter
Loading...
Awareness of the Link Between HPV and Cervical Cancer Has Declined
Most people are also not aware that HPV can cause anal, oral, and penile cancers ORLANDO, Fla. – Americans...
Colorectal Cancer Patients With African Ancestry Had Fewer Clinically Actionable Alterations Than White Patients
ORLANDO, Fla. – Genomic profiling of patients who were treated for colorectal cancer at a major U.S. cancer center...
Lung Cancer Incidence Rates Varied Significantly Among Florida’s Black and Hispanic Ethnic Subgroups
Disaggregating statistics revealed key differences in ethnic populations ORLANDO, Fla. – An analysis of lung cancer incidence rates showed...
Single-agent Pembrolizumab May Benefit Patients with Rare Type of Skin Cancer
ORLANDO, Fla. – Monotherapy with pembrolizumab (Keytruda) led to clinical responses in 89% of patients with unresectable metastatic desmoplastic...
A Liquid Biopsy-based Multicancer Early Detection Test May Detect Early-stage Disease and Low DNA-shedding Cancers
The multicancer early detection platform was developed based on methylation of cell-free DNA ORLANDO, Fla. – A liquid biopsy-based...
Adjuvant Treatment With Atezolizumab and Bevacizumab May Delay Recurrence After Surgical Resection in Patients With Liver Cancer
ORLANDO, Fla. – Adjuvant therapy with atezolizumab (Tecentriq) and bevacizumab (Avastin) increased recurrence-free survival of patients with hepatocellular carcinoma...
Adding a Personalized mRNA Cancer Vaccine to Immunotherapy May Prolong Recurrence-free Survival in Patients With High-risk Melanoma
Clinical benefit was independent of patients’ tumor mutational burden ORLANDO, Fla. – mRNA-4157/V940, a personalized mRNA-based cancer vaccine,...
First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers
ORLANDO, Fla. – The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated...
Durvalumab-based Treatment Before and After Surgery Improved Outcomes for Patients With Resectable Non-small Cell Lung Cancer
Patients treated with the durvalumab-based regimen before and after surgery in the AEGEAN trial had a 32% reduction in...